









Markets
/
Stocks
/
nasdaq-coch
/

Envoy Medical Inc

COCH

0.732USD

+0.006+0.88%

Market hours （ET）Quotes delayed by 15 min

15.74MMarket Cap

LossP/E TTM



Envoy Medical Inc

0.732

+0.006+0.88%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Envoy Medical Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Envoy Medical Inc's Score

Industry at a Glance

Industry Ranking

123 / 210

Overall Ranking

261 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.833

Target Price

+925.71%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Envoy Medical Inc Highlights

StrengthsRisks

Envoy Medical, Inc. is a hearing health company. The Company is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Growing

The company is in a growing phase, with the latest annual income totaling USD 225.00K.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 225.00K.

Overvalued

The company’s latest PE is -0.51, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 12.73M shares, increasing 40.22% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 394.96K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 3.14.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 5.97, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 78.00K, representing a year-over-year increase of 14.71%, while its net profit experienced a year-over-year increase of 30.69%.

Score

Industry at a Glance

Previous score

5.97

Change



Financials

5.68

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.39

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.58

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.07

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.12

Key Metrics

Free cash flow

No Data

Envoy Medical Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 8.74, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.51, which is -100.00% below the recent high of 0.00 and -2308.30% above the recent low of -12.39.

Score

Industry at a Glance

Previous score

8.74

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 123/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Envoy Medical Inc is 8.00, with a high of 9.50 and a low of 6.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 3 analysts

Buy

Current Rating

7.833

Target Price

+980.16%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Envoy Medical Inc

COCH

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 6.67, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 0.93 and the support level at 0.61, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.69

Change

-0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.002

Neutral

RSI(14)

39.921

Neutral

STOCH(KDJ)(9,3,3)

22.825

Neutral

ATR(14)

0.073

Low Volatility

CCI(14)

-172.368

Sell

Williams %R

89.237

Oversold

TRIX(12,20)

-1.031

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.765

Sell

MA10

0.791

Sell

MA20

0.840

Sell

MA50

1.012

Sell

MA100

1.240

Sell

MA200

1.353

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 44.52%, representing a quarter-over-quarter decrease of 59.14%. The largest institutional shareholder is The Vanguard, holding a total of 394.96K shares, representing 1.38% of shares outstanding, with 25.63% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

NorthRock Partners, LLC

10.29M

Taylor (Glen A)

10.29M

Atlas Merchant Capital LLC

555.53K

The Vanguard Group, Inc.

Star Investors

394.96K

Weiss Asset Management

368.14K

-5.11%

Lucas (Brent T)

209.46K

+3.84%

Focus Partners Wealth, LLC

212.66K

DSG Capital Advisors, LLC

163.64K

Arcus Capital Partners, LLC

187.57K

Meteora Capital LLC

108.51K

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.28, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 2.07. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.